I agree that this site is using cookies. You can find further informations here.
X
Chanan-Khan, A.
228  results:
Search for persons X
?
1

EE667 Cost-Minimization Analysis (CMA) of Bruton Tyrosine K..:

Chanan-Khan, A. ; Mohseninejad, L. ; Walder, L....
Value in Health.  26 (2023)  12 - p. S182 , 2023
Link: https://doi.org/10.1016/..
 
?
2

PB1888: EFFICACY OF FIRST-LINE TREATMENT FOR CHRONIC LYMPHO..:

Chanan-Khan, A. ; Yang, K. ; Liu, T....
HemaSphere.  6 (2022)  - p. 1767-1768 , 2022
Link: https://doi.org/10.1097/..
 
?
3

PB1887: NETWORK META-ANALYSIS OF PROGRESSION FREE SURVIVAL ..:

Chanan-Khan, A. ; Liu, T. ; Yang, K....
HemaSphere.  6 (2022)  - p. 1766-1767 , 2022
Link: https://doi.org/10.1097/..
 
?
4

P685: REAL WORLD EVIDENCE OF IMPACT OF ATRIAL FIBRILLATION ..:

Yang, K. ; Liu, T. ; Tang, B..
HemaSphere.  6 (2022)  - p. 581-582 , 2022
Link: https://doi.org/10.1097/..
 
?
5

S171: MOLECULAR CLUSTERS OF IGM MONOCLONAL GAMMOPATHIES PRE..:

Mondello, P. ; Paludo, J. ; Novak, J....
HemaSphere.  6 (2022)  - p. 72-73 , 2022
Link: https://doi.org/10.1097/..
 
?
6

P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS B..:

Sonneveld, P ; Chanan-Khan, A ; Weisel, K...
HemaSphere.  6 (2022)  - p. 12-12 , 2022
Link: https://doi.org/10.1097/..
 
?
7

Updated results from the phase 3 HELIOS study of ibrutinib,..:

Fraser, G. ; Cramer, P. ; Demirkan, F....
Leukemia.  33 (2018)  4 - p. 969-980 , 2018
Link: https://doi.org/10.1038/..
 
?
8

Pomalidomide–dexamethasone in refractory multiple myeloma: ..:

Ailawadhi, S ; Mikhael, J R ; LaPlant, B R...
Leukemia.  32 (2017)  3 - p. 719-728 , 2017
Link: https://doi.org/10.1038/..
 
?
9

Randomized phase 3 study of lenalidomide versus chlorambuci..:

Chanan-Khan, A ; Egyed, M ; Robak, T...
Leukemia.  31 (2017)  5 - p. 1240-1243 , 2017
Link: https://doi.org/10.1038/..
 
?
10

Waldenstrom macroglobulinemia cells devoid of BTKC481S or C..:

Paulus, A ; Akhtar, S ; Yousaf, H...
Blood Cancer Journal.  7 (2017)  5 - p. e565-e565 , 2017
Link: https://doi.org/10.1038/..
 
?
11

Coinhibition of the deubiquitinating enzymes, USP14 and UCH..:

Paulus, A ; Akhtar, S ; Caulfield, T R...
Blood Cancer Journal.  6 (2016)  11 - p. e492-e492 , 2016
Link: https://doi.org/10.1038/..
 
?
12

Lenalidomide treatment and prognostic markers in relapsed o..:

Bühler, A ; Wendtner, C-M ; Kipps, T J...
Blood Cancer Journal.  6 (2016)  3 - p. e404-e404 , 2016
Link: https://doi.org/10.1038/..
 
?
13

Phase 2 trial of ixazomib in patients with relapsed multipl..:

Kumar, S K ; LaPlant, B ; Roy, V...
Blood Cancer Journal.  5 (2015)  8 - p. e338-e338 , 2015
Link: https://doi.org/10.1038/..
 
?
14

Phase 1b Interim Results: Venetoclax (ABT-199/GDC-0199) in ..:

Touzeau, C. ; Chanan-Khan, A. ; Roberts, A.W....
Clinical Lymphoma Myeloma and Leukemia.  15 (2015)  - p. e272-e273 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Variable risk of second primary malignancy in multiple myel..:

Ailawadhi, S ; Swaika, A ; Razavi, P..
Blood Cancer Journal.  4 (2014)  9 - p. e243-e243 , 2014
Link: https://doi.org/10.1038/..
 
1-15